EDIT($417M) has a higher market cap than ZNTL($332M). ZNTL YTD gains are higher at: 160.000 vs. EDIT (31.707). EDIT has higher annual earnings (EBITDA): -67.46M vs. ZNTL (-152.75M). EDIT has more cash in the bank: 212M vs. ZNTL (175M). EDIT has less debt than ZNTL: EDIT (15.5M) vs ZNTL (33.6M). EDIT has higher revenues than ZNTL: EDIT (47M) vs ZNTL (0).

	EDIT	ZNTL	EDIT / ZNTL
Capitalization	417M	332M	126%
EBITDA	-67.46M	-152.75M	44%
Gain YTD	31.707	160.000	20%
P/E Ratio	N/A	N/A	-
Revenue	47M	0	-
Total Cash	212M	175M	121%
Total Debt	15.5M	33.6M	46%

FUNDAMENTALS RATINGS

EDIT vs ZNTL: Fundamental Ratings

	EDIT	ZNTL
OUTLOOK RATING 1..100	27	61
VALUATION overvalued / fair valued / undervalued 1..100	34 Fair valued	23 Undervalued
PROFIT vs RISK RATING 1..100	100	100
SMR RATING 1..100	99	98
PRICE GROWTH RATING 1..100	56	39
P/E GROWTH RATING 1..100	100	100
SEASONALITY SCORE 1..100	50	50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZNTL's Valuation (23) in the null industry is in the same range as EDIT (34) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to EDIT’s over the last 12 months.

ZNTL's Profit vs Risk Rating (100) in the null industry is in the same range as EDIT (100) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to EDIT’s over the last 12 months.

ZNTL's SMR Rating (98) in the null industry is in the same range as EDIT (99) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to EDIT’s over the last 12 months.

ZNTL's Price Growth Rating (39) in the null industry is in the same range as EDIT (56) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to EDIT’s over the last 12 months.

ZNTL's P/E Growth Rating (100) in the null industry is in the same range as EDIT (100) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to EDIT’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	EDIT	ZNTL
RSI ODDS (%)	2 days ago 90%	2 days ago 86%
Stochastic ODDS (%)	2 days ago 81%	2 days ago 84%
Momentum ODDS (%)	2 days ago 90%	2 days ago 87%
MACD ODDS (%)	2 days ago 90%	2 days ago 90%
TrendWeek ODDS (%)	2 days ago 90%	2 days ago 86%
TrendMonth ODDS (%)	2 days ago 89%	2 days ago 84%
Advances ODDS (%)	11 days ago 79%	10 days ago 84%
Declines ODDS (%)	3 days ago 90%	2 days ago 88%
BollingerBands ODDS (%)	2 days ago 83%	2 days ago 90%
Aroon ODDS (%)	2 days ago 80%	2 days ago 85%

COMPARISON

Comparison

Sep 13, 2026

Stock price -- (EDIT: $2.70 vs. ZNTL: $3.51)

Brand notoriety: EDIT and ZNTL are both not notable

Both companies represent the Biotechnology industry

Current volume relative to the 65-day Moving Average: EDIT: 121% vs. ZNTL: 80%

Market capitalization -- EDIT: $416.97M vs. ZNTL: $331.83M

EDIT [@Biotechnology] is valued at $416.97M. ZNTL’s [@Biotechnology] market capitalization is $331.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green while ZNTL’s FA Score has 1 green FA rating(s).

EDIT’s FA Score: 0 green, 5 red.
ZNTL’s FA Score: 1 green, 4 red.

According to our system of comparison, ZNTL is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 3 bullish TA indicator(s).

EDIT’s TA Score: 4 bullish, 6 bearish.
ZNTL’s TA Score: 3 bullish, 7 bearish.

According to our system of comparison, EDIT is a better buy in the short-term than ZNTL.

Price Growth

EDIT (@Biotechnology) experienced а -16.41% price change this week, while ZNTL (@Biotechnology) price change was -12.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 09, 2026.

ZNTL is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three

EDIT

Daily Signal:

Gain/Loss:

ZNTL

Setup

Daily Signal:

Description

Gain/Loss:

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
NBIIX	14.93	0.08	+0.54%
Neuberger International Eq I
BPTRX	264.63	N/A	N/A
Baron Partners Retail
FMCDX	49.88	N/A	N/A
Fidelity Advisor Stock Selec Mid Cp A
FCGBX	3.23	N/A	N/A
Templeton Global Dynamic Income C
AGLYX	16.15	N/A	N/A
Ariel Global Institutional

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with VCYT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then VCYT could also see price increases.

Ticker / NAME	Correlation To ZNTL	1D Price Change %
ZNTL	100%	-2.23%
VCYT - ZNTL	39% Loosely correlated	-2.76%
MLTX - ZNTL	38% Loosely correlated	-5.08%
LPCN - ZNTL	38% Loosely correlated	+0.89%
EDIT - ZNTL	36% Loosely correlated	+1.89%
TIL - ZNTL	35% Loosely correlated	+0.27%
More